Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis |
amyloidosis |
(Athero in RA(1 |
Athero in RA |
Biologics for JCA |
follow up biologic users |
Ig G4 related disease(1 |
Ig G4 related disease(2 |
Kawasaki disease(1 |
Kawasaki disease |
Management of severe SLE |
Non-throm Nerv Sys APS(1) |
malignancy |
Non-throm Nerv Sys APS |
Non-throm Nerv Sys APS(2) |
Management of traumatic meniscus tears |
novel imaging in rheumatology- |
Non-throm Nerv Sys APS(3) |
novelties in the treatment of RA |
Presentation1(1) |
refract sle(1 |
Rheumatoid Arthritis Vs Psoriatic Arthritis |
sclerodema jurnal(1) |
sclerodema jurnal |
ss slide |
Systemic sclerosis |
updates on RA(1) |
updates on RA |
Major & minor salivary gland swelling-1 |
Jaw osteonecrosis related to osteoporotic agents-1
|
Jaw osteonecrosis related to osteoporotic agents-1-1 |
Approach to TMJ disorders |
Vasculitis updates |
different center different device compare BMD 2 |
Same Center Same Device revised |
Sarcoidosis overview |
different center same devic e compareBMD |
Pediatric Osteoporosis |
Pyoderma ganrenosum |
Premenopausal osteoporosis |
Rheumatic diseases and covid vaccination |
Glomerulonephritis approach |
Lupus updates-1(2) |
Liver granulomatous lesions |
Antimalarial and rheumatic diseases(5) |
Lupus Pneumonitis vs covid-19 infection |
Reactive arthritis radiologic findings |
Rheumatic diseases and pregnancy(2) |
Antiphospholipid syndrome 2 |
RA radiologic findings |
ANCA associated vasculitis 2(3) |
Covid vaccination |
osteonecrosis2(1) |
Infections in rheumatic diseases(3) |
Neuropsychiatric lupus(1) |
Sarcoidosis and large vessel vasculitis(6) |
Sarcoidosis and large vessel vasculitis(7) |
Anticoagulant drugs(2) |
Shoulder imaging |
Rheumatoid Arthritis & lung involvement |
Q10 and autoimmune diseases(1) |
Idiopathic Inflammatory Myositis clinical features, diagnosis, treatment |
Spondyloarthritis treatment updates(4) |
Spondyloarthritis treatment updates(6) |
Systemic Sclerosis organ based management II 2(6) |
Oral ulcer approach |
CPPD disease |
Cutaneous manifestations of rheumatic diseases 2(1) |
Cutaneous manifestations of rheumatic diseases 2 |
Foot & ankle radiology |
Glucocorticoid-induced osteoporosis 3 |
Glucocorticoid-induced osteoporosis 4 |
GPA overview |
Lupus and pleurisy |
Oral ulcer approach (2) |
Psoriatic arthritis radiologic findings 2(2) |
Proliferative bone diseases |
Proliferative bone diseases(1) |
Osteoarthritis radiologic scoring system |
CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES |
Covid and vasculitis |
Diabetic foot ulcer |
Muscle weakness |
NSAIDs and rheumatology |
Osteoarthritis pathogenesis 2 |
Osteoarthritis pathogenesis 3 |
Osteoarticular tuberculosis |
Osteoarthritis treatment 2(1) |
Osteoarthritis treatment 2 |
Systemic sclerosis and digital ulcer |
Recurrent uveitis & myelitis approach |
Relapsing polychondritis(1) |
Relapsing polychondritis(2) |
Relapsing polychondritis |
Relapsing polychondritis |
Skin Vasculitis(1) |
Skin Vasculitis |
Epigenetics Vs genetics(1) |
Epigenetics Vs genetics |
Eye and rheumatic diseases |
GI involvement in systemic sclerosis(1) |
GI involvement in systemic sclerosis |
T Lymphocyte & Rheumatic diseases |
Behcet’s Syndrome from etilogy to treatment 2 |
Chronic Foot Ulcer Approach |
Dermatomyositis and infection |
Hypergammaglobulinemia |
Idiopathic Granulomatous Mastitis |
Normal variants in skeletal radiology |
Scleroderma like disorders |
|